Walgreens Boots Alliance Inc (WBA) Shares Sold by Gofen & Glossberg LLC IL

Gofen & Glossberg LLC IL lessened its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 103,227 shares of the pharmacy operator’s stock after selling 5,945 shares during the quarter. Gofen & Glossberg LLC IL’s holdings in Walgreens Boots Alliance were worth $6,195,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in WBA. Captrust Financial Advisors acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $194,000. Elkfork Partners LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $9,766,000. OLD Mission Capital LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $316,000. Cornerstone Capital Management Holdings LLC. boosted its holdings in Walgreens Boots Alliance by 4.3% during the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 185,920 shares of the pharmacy operator’s stock worth $13,500,000 after purchasing an additional 7,698 shares during the last quarter. Finally, Ladenburg Thalmann Financial Services Inc. boosted its holdings in Walgreens Boots Alliance by 12.0% during the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 81,432 shares of the pharmacy operator’s stock worth $5,917,000 after purchasing an additional 8,712 shares during the last quarter. Institutional investors own 60.27% of the company’s stock.

Several research analysts recently commented on the stock. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Friday, June 22nd. Jefferies Financial Group cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating and reduced their target price for the stock from $85.00 to $65.00 in a report on Friday, June 29th. Pivotal Research dropped their price target on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating on the stock in a research report on Monday, July 2nd. Citigroup lowered shares of Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $69.00 price target on the stock. in a research report on Monday. Finally, Loop Capital upped their price target on shares of Walgreens Boots Alliance to $80.00 and gave the stock a “buy” rating in a research report on Friday, June 29th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $77.84.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Wednesday, May 2nd. The shares were sold at an average price of $65.56, for a total value of $179,372.16. Following the transaction, the director now directly owns 13,679 shares of the company’s stock, valued at $896,795.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is owned by corporate insiders.

Walgreens Boots Alliance opened at $63.66 on Thursday, according to MarketBeat. The firm has a market cap of $63.25 billion, a price-to-earnings ratio of 12.48, a PEG ratio of 1.05 and a beta of 1.12. Walgreens Boots Alliance Inc has a 1 year low of $59.07 and a 1 year high of $83.89. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.47 by $0.06. The company had revenue of $34.33 billion for the quarter, compared to analyst estimates of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The company’s revenue was up 14.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.33 earnings per share. equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.97 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 12th. Stockholders of record on Monday, August 20th will be given a $0.44 dividend. The ex-dividend date is Friday, August 17th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. This represents a $1.76 annualized dividend and a dividend yield of 2.76%. Walgreens Boots Alliance’s dividend payout ratio is presently 31.37%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply